Polio vaccination campaign set to resume amidst challenges in Gaza

A third phase of the polio vaccination campaign is set to begin tomorrow in part of the northern Gaza Strip after being postponed from 23 October 2024 due to lack of access and assured, comprehensive humanitarian pauses, intense bombardment, and mass evacuation orders.

San Diego biotech secures $75M to advance lead candidate

Arthrosi Therapeutics, a biotech company developing a gout treatment, raised a fresh $75 million through a Series D round. According to a press release on

July 13, 2023

AstraZeneca lands FDA approval for AKT inhibitor in biomarker-defined breast cancer subset

AstraZeneca has scored an FDA approval for its AKT inhibitor capivasertib, adding a new targeted therapy to its treatment offerings in breast cancer. The drug,

November 18, 2023

Oncolytic Virus for Human Papillomavirus Associated Cancer, Human Papillomavirus Infections and Coronavirus Disease 2019 (COVID-19) by Blue Sky Immunotherapies for Cervical Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.